Norepinephrine for Spinal-induced Hypotension

Prophylactic Norepinephrine Infusion for Spinal-induced Hypotension

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03308708

Acronym

NE in spianl

Enrollment

Registered

2017-10-12

Start date

2017-11-01

Completion date

2018-01-01

Last updated

2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anesthesia

Brief summary

Norepinephrine (NE) infusion is used prophylactically to counteract the vasodilator effect of spinal anesthesia. prophylactic use of NE infusion is expected to decrease bouts of hypotension, vomiting and increase patient satisfaction

Interventions

DRUGNorepinephrine infusion

Norepinephrine infusion (5miclml) is immediately started after spinal anesthesia. Rate starts at 30 ml/h and modified according to hemodynamic state

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

* All patients scheduled for elective surgery under spinal anesthesia

Exclusion criteria

* ischemic heart disease uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame	Description
incidence of hypotension	intraoperative	intraoperative decrease of patient blood pressure by more than 20% from its basal reading

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026